Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Action of Fluticasone Furoate vs Olopatadine in Allergic Rhinitis
NCT01076439Phase 4Withdrawn
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of fluticasone and olopatadine in allergic rhinitis (AR) (3 arms). Primary endpoint: Total Nasal Symptom Score. Status: withdrawn.
02
Drugs
fluticasoneolopatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01076439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01076439.